MELINTA THERAPEUTICS, INC. /NEW/ Retained Earnings
MELINTA THERAPEUTICS, INC. /NEW/ had Retained Earnings of -$997.88 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2019-11-12
- 2019-09-30: Retained Earnings (Accumulated Deficit) -$997.88M.
- 2019-06-30: Retained Earnings (Accumulated Deficit) -$784.50M.
- 2019-03-31: Retained Earnings (Accumulated Deficit) -$748.32M.
- 2018-12-31: Retained Earnings (Accumulated Deficit) -$719.84M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2019-09-30 | -$997.88M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$784.50M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$748.32M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | -$719.84M 10-Q · filed 2019-11-12 | |
| 2018-09-30 | -$675.72M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | -$647.86M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$592.08M 10-Q · filed 2018-05-10 | |
| 2018-01-01 | -$562.65M 10-K · filed 2019-03-14 | |
| 2017-12-31 | -$572.66M 10-K · filed 2019-03-14 | |
| 2017-09-30 | -$482.50M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | -$472.14M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$459.87M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | -$513.74M 10-K · filed 2018-03-16 | -$436.98M 10-K · filed 2017-02-28 |
| 2016-09-30 | -$405.55M 10-Q · filed 2016-10-27 | |
| 2016-06-30 | -$373.23M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | -$348.43M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | -$319.02M 10-K · filed 2017-02-28 | -$319.02M 10-K · filed 2016-02-25 |
| 2015-09-30 | -$297.87M 10-Q · filed 2015-10-22 | |
| 2015-06-30 | -$270.30M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | -$245.33M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | -$227.91M 10-K · filed 2016-02-25 | |
| 2014-09-30 | -$211.01M 10-Q · filed 2014-10-29 | |
| 2014-06-30 | -$199.66M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | -$183.28M 10-Q · filed 2014-04-29 | |
| 2013-12-31 | -$166.26M 10-K · filed 2015-02-26 | |
| 2012-12-31 | -$121.23M 10-K · filed 2014-02-28 |